| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papio | 59 | 2020 | 91 | 6.530 |
Why?
|
| Liver | 15 | 2018 | 486 | 2.200 |
Why?
|
| Animals | 97 | 2020 | 7694 | 2.150 |
Why?
|
| Gene Expression Profiling | 15 | 2013 | 326 | 1.890 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 10 | 2018 | 16 | 1.840 |
Why?
|
| Quantitative Trait Loci | 20 | 2015 | 143 | 1.830 |
Why?
|
| Fetus | 9 | 2018 | 86 | 1.750 |
Why?
|
| Cholesterol, LDL | 9 | 2019 | 172 | 1.750 |
Why?
|
| Kidney | 10 | 2018 | 529 | 1.740 |
Why?
|
| Papio hamadryas | 12 | 2019 | 15 | 1.640 |
Why?
|
| Atherosclerosis | 8 | 2019 | 770 | 1.620 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 502 | 1.500 |
Why?
|
| MicroRNAs | 5 | 2019 | 180 | 1.450 |
Why?
|
| Cholesterol, Dietary | 6 | 2019 | 36 | 1.220 |
Why?
|
| Gene Expression Regulation, Developmental | 12 | 2019 | 69 | 1.210 |
Why?
|
| Cholesterol, HDL | 5 | 2012 | 176 | 1.100 |
Why?
|
| Pregnancy | 21 | 2019 | 1010 | 1.100 |
Why?
|
| Metabolomics | 3 | 2019 | 53 | 1.000 |
Why?
|
| Genomics | 5 | 2019 | 85 | 0.990 |
Why?
|
| Genetic Variation | 14 | 2019 | 247 | 0.960 |
Why?
|
| Hypertension | 6 | 2017 | 972 | 0.940 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 1040 | 0.920 |
Why?
|
| Fetal Growth Retardation | 4 | 2019 | 34 | 0.900 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 104 | 0.890 |
Why?
|
| Proteomics | 3 | 2019 | 94 | 0.880 |
Why?
|
| Obesity | 7 | 2018 | 1164 | 0.880 |
Why?
|
| Fetal Development | 4 | 2018 | 25 | 0.870 |
Why?
|
| Lipase | 4 | 2011 | 27 | 0.860 |
Why?
|
| Iliac Artery | 2 | 2019 | 49 | 0.850 |
Why?
|
| Endothelium, Vascular | 3 | 2015 | 154 | 0.830 |
Why?
|
| Genome | 7 | 2012 | 38 | 0.830 |
Why?
|
| Cholesterol | 4 | 2019 | 251 | 0.810 |
Why?
|
| Diet | 6 | 2019 | 384 | 0.800 |
Why?
|
| Dietary Fats | 4 | 2019 | 110 | 0.780 |
Why?
|
| RNA, Messenger | 15 | 2018 | 534 | 0.770 |
Why?
|
| Female | 58 | 2020 | 20126 | 0.750 |
Why?
|
| Antiporters | 3 | 2017 | 9 | 0.710 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2019 | 57 | 0.700 |
Why?
|
| Promoter Regions, Genetic | 3 | 2011 | 213 | 0.700 |
Why?
|
| Cardiovascular Diseases | 5 | 2017 | 1133 | 0.700 |
Why?
|
| Leukocytes | 2 | 2019 | 60 | 0.700 |
Why?
|
| Phylogeny | 7 | 2019 | 56 | 0.690 |
Why?
|
| Phenotype | 17 | 2018 | 656 | 0.690 |
Why?
|
| Papio anubis | 5 | 2019 | 8 | 0.660 |
Why?
|
| Male | 45 | 2020 | 19488 | 0.650 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2019 | 28 | 0.650 |
Why?
|
| Chromosome Mapping | 12 | 2015 | 193 | 0.640 |
Why?
|
| Breath Tests | 1 | 2018 | 21 | 0.640 |
Why?
|
| Molecular Sequence Data | 16 | 2011 | 359 | 0.630 |
Why?
|
| Volatile Organic Compounds | 1 | 2018 | 7 | 0.630 |
Why?
|
| DNA Methylation | 2 | 2009 | 142 | 0.630 |
Why?
|
| Sequence Analysis, RNA | 3 | 2017 | 29 | 0.620 |
Why?
|
| Animal Nutritional Physiological Phenomena | 5 | 2017 | 9 | 0.620 |
Why?
|
| Papio cynocephalus | 5 | 2019 | 6 | 0.620 |
Why?
|
| Cardiovascular System | 1 | 2018 | 45 | 0.620 |
Why?
|
| Malnutrition | 3 | 2018 | 17 | 0.610 |
Why?
|
| Primates | 3 | 2017 | 111 | 0.600 |
Why?
|
| Amino Acid Sequence | 16 | 2011 | 287 | 0.590 |
Why?
|
| Sodium, Dietary | 1 | 2017 | 25 | 0.570 |
Why?
|
| Computational Biology | 3 | 2019 | 90 | 0.550 |
Why?
|
| Placenta | 3 | 2013 | 74 | 0.530 |
Why?
|
| Proteome | 2 | 2006 | 39 | 0.530 |
Why?
|
| Pregnancy, Animal | 2 | 2013 | 19 | 0.530 |
Why?
|
| Carboxylesterase | 3 | 2010 | 3 | 0.520 |
Why?
|
| Humans | 49 | 2020 | 32297 | 0.520 |
Why?
|
| Renin-Angiotensin System | 1 | 2017 | 188 | 0.510 |
Why?
|
| Angiotensin II | 1 | 2017 | 263 | 0.510 |
Why?
|
| Proteoglycans | 1 | 2015 | 32 | 0.510 |
Why?
|
| Blood Pressure | 3 | 2017 | 859 | 0.500 |
Why?
|
| Sequence Alignment | 9 | 2012 | 61 | 0.500 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2012 | 163 | 0.490 |
Why?
|
| Pedigree | 13 | 2020 | 141 | 0.480 |
Why?
|
| Inflammation | 3 | 2015 | 542 | 0.480 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 149 | 0.470 |
Why?
|
| Endothelial Cells | 3 | 2012 | 187 | 0.460 |
Why?
|
| Sepsis | 1 | 2015 | 156 | 0.450 |
Why?
|
| Genotype | 14 | 2019 | 742 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2016 | 1092 | 0.430 |
Why?
|
| Fetal Heart | 1 | 2012 | 5 | 0.420 |
Why?
|
| Chromosomes, Mammalian | 4 | 2009 | 13 | 0.400 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 14 | 0.390 |
Why?
|
| Vertebrates | 1 | 2011 | 2 | 0.390 |
Why?
|
| Lipoproteins, VLDL | 1 | 2011 | 27 | 0.390 |
Why?
|
| Base Sequence | 10 | 2019 | 257 | 0.380 |
Why?
|
| Serum | 3 | 2019 | 20 | 0.370 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2018 | 90 | 0.370 |
Why?
|
| Food Deprivation | 2 | 2007 | 3 | 0.360 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 1 | 0.360 |
Why?
|
| Gestational Age | 5 | 2015 | 122 | 0.360 |
Why?
|
| Lymphocytes | 1 | 2010 | 58 | 0.360 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2013 | 264 | 0.360 |
Why?
|
| Appetite | 1 | 2009 | 23 | 0.350 |
Why?
|
| Genetic Techniques | 1 | 2009 | 7 | 0.350 |
Why?
|
| Lipid Metabolism | 4 | 2018 | 103 | 0.340 |
Why?
|
| Rats | 8 | 2018 | 1675 | 0.330 |
Why?
|
| Species Specificity | 9 | 2020 | 90 | 0.330 |
Why?
|
| Principal Component Analysis | 2 | 2019 | 68 | 0.320 |
Why?
|
| Protein Structure, Tertiary | 5 | 2011 | 102 | 0.320 |
Why?
|
| Transcription Factors | 1 | 2009 | 181 | 0.320 |
Why?
|
| Lipids | 3 | 2018 | 226 | 0.300 |
Why?
|
| Aging | 4 | 2019 | 953 | 0.300 |
Why?
|
| Hominidae | 2 | 2020 | 3 | 0.300 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2007 | 5 | 0.300 |
Why?
|
| Embryonic Development | 1 | 2007 | 8 | 0.300 |
Why?
|
| Chromosomes | 2 | 2006 | 9 | 0.290 |
Why?
|
| Models, Animal | 8 | 2016 | 164 | 0.290 |
Why?
|
| Protein Kinases | 1 | 2006 | 27 | 0.290 |
Why?
|
| Exons | 4 | 2011 | 52 | 0.280 |
Why?
|
| Sequence Analysis, DNA | 5 | 2012 | 136 | 0.270 |
Why?
|
| Models, Genetic | 5 | 2020 | 94 | 0.260 |
Why?
|
| Macaca mulatta | 3 | 2016 | 332 | 0.260 |
Why?
|
| Transcription, Genetic | 4 | 2011 | 143 | 0.260 |
Why?
|
| Reproducibility of Results | 5 | 2015 | 779 | 0.260 |
Why?
|
| Signal Transduction | 5 | 2020 | 701 | 0.260 |
Why?
|
| Genes | 4 | 2010 | 15 | 0.260 |
Why?
|
| Aorta | 2 | 2019 | 126 | 0.250 |
Why?
|
| Sex Factors | 5 | 2020 | 674 | 0.250 |
Why?
|
| Heart | 3 | 2013 | 182 | 0.240 |
Why?
|
| Cattle | 4 | 2012 | 101 | 0.240 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2011 | 71 | 0.230 |
Why?
|
| DNA, Complementary | 5 | 2009 | 33 | 0.230 |
Why?
|
| Nutritional Status | 2 | 2017 | 73 | 0.230 |
Why?
|
| Protein Structure, Secondary | 4 | 2011 | 47 | 0.220 |
Why?
|
| RNA, Untranslated | 2 | 2013 | 10 | 0.220 |
Why?
|
| Blood Glucose | 2 | 2020 | 496 | 0.210 |
Why?
|
| Brain | 5 | 2015 | 971 | 0.210 |
Why?
|
| Caloric Restriction | 2 | 2017 | 96 | 0.210 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 13 | 0.210 |
Why?
|
| Polymorphism, Genetic | 4 | 2019 | 194 | 0.210 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 110 | 0.210 |
Why?
|
| Models, Molecular | 3 | 2011 | 197 | 0.210 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 545 | 0.210 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2018 | 22 | 0.200 |
Why?
|
| Mice | 9 | 2016 | 2524 | 0.200 |
Why?
|
| Hydrocortisone | 2 | 2018 | 61 | 0.200 |
Why?
|
| Quantitative Trait, Heritable | 7 | 2005 | 47 | 0.200 |
Why?
|
| Trophoblasts | 2 | 2019 | 10 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 45 | 0.190 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 19 | 0.190 |
Why?
|
| Surface Plasmon Resonance | 1 | 2020 | 7 | 0.190 |
Why?
|
| Dengue | 1 | 2020 | 5 | 0.190 |
Why?
|
| Reproduction | 1 | 2020 | 12 | 0.190 |
Why?
|
| Quadriceps Muscle | 1 | 2020 | 36 | 0.180 |
Why?
|
| Aorta, Thoracic | 2 | 2019 | 85 | 0.180 |
Why?
|
| Hybridization, Genetic | 2 | 2019 | 3 | 0.180 |
Why?
|
| DNA Primers | 3 | 2010 | 90 | 0.180 |
Why?
|
| Biosensing Techniques | 1 | 2020 | 25 | 0.180 |
Why?
|
| Spermatozoa | 1 | 2020 | 59 | 0.180 |
Why?
|
| Prediabetic State | 1 | 2020 | 65 | 0.180 |
Why?
|
| Gene Duplication | 2 | 2011 | 5 | 0.180 |
Why?
|
| Asparagine | 1 | 2019 | 6 | 0.170 |
Why?
|
| Alternative Splicing | 2 | 1999 | 30 | 0.170 |
Why?
|
| Organ Specificity | 3 | 2018 | 81 | 0.170 |
Why?
|
| Placental Insufficiency | 1 | 2019 | 1 | 0.170 |
Why?
|
| Lactic Acid | 1 | 2019 | 53 | 0.170 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 245 | 0.160 |
Why?
|
| Adipocytes | 2 | 2010 | 79 | 0.160 |
Why?
|
| Exhalation | 1 | 2018 | 5 | 0.160 |
Why?
|
| Sequence Deletion | 1 | 1998 | 40 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 20 | 0.160 |
Why?
|
| Kidney Cortex | 1 | 2018 | 25 | 0.160 |
Why?
|
| Kidney Medulla | 1 | 2018 | 29 | 0.160 |
Why?
|
| Lipoprotein(a) | 1 | 1998 | 20 | 0.160 |
Why?
|
| Birth Weight | 1 | 2018 | 46 | 0.160 |
Why?
|
| Metabolome | 1 | 2018 | 36 | 0.160 |
Why?
|
| Chagas Disease | 1 | 2017 | 6 | 0.150 |
Why?
|
| Lod Score | 5 | 2009 | 72 | 0.150 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2008 | 9 | 0.150 |
Why?
|
| Risk Factors | 6 | 2019 | 3876 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2011 | 849 | 0.150 |
Why?
|
| Diet, Atherogenic | 2 | 2017 | 61 | 0.150 |
Why?
|
| Gene Order | 2 | 2011 | 6 | 0.150 |
Why?
|
| Subcutaneous Fat | 1 | 2018 | 46 | 0.150 |
Why?
|
| Reference Standards | 2 | 2017 | 33 | 0.150 |
Why?
|
| Monkey Diseases | 1 | 2017 | 18 | 0.150 |
Why?
|
| Databases, Genetic | 2 | 2017 | 37 | 0.150 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2015 | 41 | 0.150 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 105 | 0.150 |
Why?
|
| Mitochondria | 2 | 2019 | 188 | 0.150 |
Why?
|
| Glucose | 1 | 2018 | 177 | 0.150 |
Why?
|
| Cell Differentiation | 3 | 2016 | 468 | 0.150 |
Why?
|
| Forearm | 2 | 2015 | 43 | 0.140 |
Why?
|
| Osteocalcin | 2 | 2006 | 9 | 0.140 |
Why?
|
| Myeloid Cells | 1 | 2016 | 40 | 0.140 |
Why?
|
| Caspase 3 | 2 | 2013 | 31 | 0.140 |
Why?
|
| Insulin | 1 | 2018 | 368 | 0.140 |
Why?
|
| Apolipoproteins | 1 | 1998 | 200 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2016 | 105 | 0.140 |
Why?
|
| Tissue Distribution | 2 | 2006 | 62 | 0.130 |
Why?
|
| Multigene Family | 3 | 2010 | 51 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2013 | 58 | 0.130 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 119 | 0.130 |
Why?
|
| Gene Expression | 3 | 2013 | 345 | 0.130 |
Why?
|
| Nitroprusside | 1 | 2015 | 5 | 0.130 |
Why?
|
| Genes, Mitochondrial | 1 | 2015 | 2 | 0.130 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 17 | 0.130 |
Why?
|
| Nitroglycerin | 1 | 2015 | 11 | 0.130 |
Why?
|
| Endotoxemia | 1 | 2015 | 7 | 0.130 |
Why?
|
| Personality | 1 | 2015 | 16 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2013 | 305 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2006 | 20 | 0.130 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 80 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 57 | 0.130 |
Why?
|
| Organ Size | 3 | 2009 | 220 | 0.120 |
Why?
|
| Vasodilation | 1 | 2015 | 93 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 600 | 0.120 |
Why?
|
| Erythrocytes | 2 | 2013 | 45 | 0.120 |
Why?
|
| Cloning, Molecular | 4 | 2009 | 76 | 0.120 |
Why?
|
| Lipoproteins | 2 | 2017 | 84 | 0.120 |
Why?
|
| Dogs | 2 | 2011 | 129 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 137 | 0.120 |
Why?
|
| Young Adult | 3 | 2019 | 2626 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1994 | 35 | 0.120 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 16 | 0.120 |
Why?
|
| Adipose Tissue | 3 | 2008 | 345 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 190 | 0.110 |
Why?
|
| INDEL Mutation | 1 | 2013 | 11 | 0.110 |
Why?
|
| Callithrix | 1 | 2013 | 2 | 0.110 |
Why?
|
| Chlorophyll | 1 | 2013 | 2 | 0.110 |
Why?
|
| Phytanic Acid | 1 | 2013 | 4 | 0.110 |
Why?
|
| Diet, Vegetarian | 1 | 2013 | 3 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2015 | 262 | 0.110 |
Why?
|
| Research Design | 1 | 2015 | 313 | 0.110 |
Why?
|
| Metagenome | 1 | 2012 | 5 | 0.110 |
Why?
|
| Mothers | 1 | 2013 | 87 | 0.110 |
Why?
|
| Neoplasms | 1 | 2019 | 695 | 0.110 |
Why?
|
| Femoral Artery | 1 | 2012 | 48 | 0.110 |
Why?
|
| Body Weight | 3 | 2012 | 311 | 0.100 |
Why?
|
| Pregnancy, Multiple | 1 | 2012 | 10 | 0.100 |
Why?
|
| Sheep, Domestic | 1 | 2012 | 18 | 0.100 |
Why?
|
| Myocardium | 1 | 2013 | 196 | 0.100 |
Why?
|
| Annexin A1 | 1 | 2012 | 1 | 0.100 |
Why?
|
| Colon | 1 | 2012 | 52 | 0.100 |
Why?
|
| Desoxycorticosterone | 1 | 2012 | 3 | 0.100 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2012 | 2 | 0.100 |
Why?
|
| Glutathione Transferase | 1 | 2012 | 15 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1428 | 0.100 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 1990 | 10 | 0.100 |
Why?
|
| DNA | 3 | 2009 | 229 | 0.100 |
Why?
|
| Bone Density | 3 | 2012 | 186 | 0.100 |
Why?
|
| Th2 Cells | 1 | 2011 | 15 | 0.100 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 4 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 2010 | 19 | 0.100 |
Why?
|
| Alleles | 3 | 2019 | 252 | 0.100 |
Why?
|
| Th1 Cells | 1 | 2011 | 29 | 0.100 |
Why?
|
| Guinea Pigs | 1 | 2011 | 17 | 0.100 |
Why?
|
| Biopsy | 1 | 2012 | 273 | 0.100 |
Why?
|
| Cell Survival | 2 | 2011 | 301 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 51 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 21 | 0.100 |
Why?
|
| Nerve Degeneration | 1 | 2011 | 15 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2011 | 49 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 44 | 0.090 |
Why?
|
| Adiposity | 1 | 2012 | 197 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Pseudogenes | 1 | 2010 | 5 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2010 | 36 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 6 | 0.090 |
Why?
|
| Motor Neurons | 1 | 2011 | 56 | 0.090 |
Why?
|
| Terminology as Topic | 1 | 2010 | 65 | 0.090 |
Why?
|
| Aspartate Aminotransferases | 1 | 2010 | 29 | 0.090 |
Why?
|
| Cell Size | 1 | 2010 | 38 | 0.090 |
Why?
|
| Methylation | 1 | 2010 | 6 | 0.090 |
Why?
|
| Pancreas | 1 | 2011 | 104 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2011 | 71 | 0.090 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2009 | 11 | 0.090 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 1990 | 38 | 0.090 |
Why?
|
| Genetic Markers | 3 | 2009 | 125 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 309 | 0.090 |
Why?
|
| Stem Cells | 1 | 2012 | 310 | 0.090 |
Why?
|
| Somatomedins | 1 | 2009 | 5 | 0.090 |
Why?
|
| Body Composition | 2 | 2012 | 384 | 0.090 |
Why?
|
| Serum Albumin | 1 | 2009 | 55 | 0.090 |
Why?
|
| Time Factors | 1 | 2015 | 2181 | 0.090 |
Why?
|
| Adult | 4 | 2019 | 9467 | 0.090 |
Why?
|
| Environment | 2 | 2007 | 52 | 0.090 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2009 | 10 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 40 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 55 | 0.080 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2009 | 1 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2009 | 36 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2018 | 116 | 0.080 |
Why?
|
| Opossums | 1 | 2008 | 2 | 0.080 |
Why?
|
| Ghrelin | 1 | 2008 | 2 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 107 | 0.080 |
Why?
|
| Skull | 1 | 2008 | 48 | 0.080 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2008 | 15 | 0.080 |
Why?
|
| Gene Flow | 2 | 2019 | 2 | 0.080 |
Why?
|
| Lipoproteins, HDL | 3 | 2005 | 253 | 0.070 |
Why?
|
| Adiponectin | 1 | 2008 | 104 | 0.070 |
Why?
|
| Blood Cell Count | 1 | 2007 | 28 | 0.070 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2007 | 4 | 0.070 |
Why?
|
| Retinoblastoma Protein | 2 | 1999 | 10 | 0.070 |
Why?
|
| Animal Feed | 1 | 2006 | 16 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 1994 | 759 | 0.070 |
Why?
|
| Bone Remodeling | 1 | 2006 | 9 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 39 | 0.070 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 41 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2008 | 147 | 0.070 |
Why?
|
| Osteoblasts | 1 | 2006 | 47 | 0.070 |
Why?
|
| Apolipoproteins E | 2 | 2002 | 99 | 0.070 |
Why?
|
| Betamethasone | 1 | 2007 | 53 | 0.070 |
Why?
|
| Fetal Nutrition Disorders | 1 | 2006 | 1 | 0.070 |
Why?
|
| Cell Cycle | 3 | 1999 | 78 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 110 | 0.070 |
Why?
|
| Bone and Bones | 1 | 2006 | 89 | 0.070 |
Why?
|
| Hypertension, Renal | 1 | 2006 | 29 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2005 | 15 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2007 | 161 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2013 | 602 | 0.070 |
Why?
|
| Hormones, Ectopic | 1 | 2005 | 1 | 0.060 |
Why?
|
| Aryldialkylphosphatase | 1 | 2005 | 4 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2005 | 25 | 0.060 |
Why?
|
| Omentum | 1 | 2005 | 26 | 0.060 |
Why?
|
| Lung | 1 | 2007 | 262 | 0.060 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2004 | 8 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2004 | 59 | 0.060 |
Why?
|
| Likelihood Functions | 3 | 2016 | 48 | 0.060 |
Why?
|
| Haplotypes | 2 | 2019 | 224 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2015 | 131 | 0.060 |
Why?
|
| Age Factors | 2 | 2020 | 1204 | 0.060 |
Why?
|
| Evolution, Molecular | 2 | 2016 | 34 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 18 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 410 | 0.050 |
Why?
|
| Monocytes | 2 | 2016 | 126 | 0.050 |
Why?
|
| Genome, Human | 1 | 2002 | 133 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 773 | 0.050 |
Why?
|
| Macrophages | 2 | 2016 | 194 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 122 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2002 | 146 | 0.050 |
Why?
|
| Sodium | 1 | 2001 | 39 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 10 | 0.050 |
Why?
|
| Brazil | 1 | 2020 | 16 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 17 | 0.050 |
Why?
|
| Gold | 1 | 2020 | 18 | 0.050 |
Why?
|
| Cell Division | 1 | 2020 | 98 | 0.050 |
Why?
|
| Fibrosis | 1 | 2020 | 120 | 0.050 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 16 | 0.050 |
Why?
|
| Introns | 2 | 1998 | 39 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 60 | 0.040 |
Why?
|
| Spermatogenesis | 1 | 2020 | 57 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 696 | 0.040 |
Why?
|
| Inbreeding | 1 | 2019 | 5 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2019 | 23 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1999 | 12 | 0.040 |
Why?
|
| Electron Transport | 1 | 2019 | 16 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 23 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2010 | 62 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 73 | 0.040 |
Why?
|
| RNA Interference | 1 | 2019 | 77 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2010 | 85 | 0.040 |
Why?
|
| Plasminogen | 1 | 1998 | 1 | 0.040 |
Why?
|
| Apoprotein(a) | 1 | 1998 | 1 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2018 | 83 | 0.040 |
Why?
|
| Cloning, Organism | 1 | 1998 | 12 | 0.040 |
Why?
|
| Skinfold Thickness | 1 | 2018 | 7 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 1999 | 122 | 0.040 |
Why?
|
| Pericardium | 1 | 2018 | 54 | 0.040 |
Why?
|
| Lactation | 1 | 2017 | 15 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 1999 | 260 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 94 | 0.040 |
Why?
|
| Arteries | 1 | 2017 | 68 | 0.040 |
Why?
|
| Genetic Fitness | 1 | 2016 | 2 | 0.040 |
Why?
|
| Population Density | 1 | 2016 | 8 | 0.040 |
Why?
|
| Chemokine CX3CL1 | 1 | 2016 | 4 | 0.040 |
Why?
|
| Lectins | 1 | 2016 | 10 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2018 | 176 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2016 | 51 | 0.040 |
Why?
|
| Microvessels | 1 | 2016 | 25 | 0.040 |
Why?
|
| Apolipoproteins B | 2 | 2002 | 46 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2019 | 846 | 0.030 |
Why?
|
| Kenya | 1 | 2016 | 11 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 67 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2016 | 20 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2016 | 32 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2016 | 64 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 1832 | 0.030 |
Why?
|
| Ethylene Glycols | 1 | 2015 | 8 | 0.030 |
Why?
|
| Homovanillic Acid | 1 | 2015 | 11 | 0.030 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Phenols | 1 | 2015 | 17 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1207 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 262 | 0.030 |
Why?
|
| Social Behavior | 1 | 2015 | 65 | 0.030 |
Why?
|
| Neurons, Afferent | 1 | 1994 | 55 | 0.030 |
Why?
|
| Racemases and Epimerases | 1 | 2013 | 4 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2013 | 9 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2013 | 12 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2013 | 26 | 0.030 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2012 | 1 | 0.030 |
Why?
|
| Weaning | 1 | 2012 | 6 | 0.030 |
Why?
|
| Bone Development | 1 | 2012 | 8 | 0.030 |
Why?
|
| Cecum | 1 | 2012 | 8 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 4050 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2012 | 10 | 0.030 |
Why?
|
| Feces | 1 | 2012 | 36 | 0.030 |
Why?
|
| Ligation | 1 | 2012 | 60 | 0.030 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 56 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2012 | 81 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2012 | 187 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2013 | 141 | 0.030 |
Why?
|
| Ischemia | 1 | 2012 | 100 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 112 | 0.030 |
Why?
|
| Heredity | 1 | 2011 | 13 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 2011 | 28 | 0.020 |
Why?
|
| Receptors, Somatomedin | 1 | 2011 | 2 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2011 | 8 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 18 | 0.020 |
Why?
|
| Lentivirus | 1 | 2011 | 11 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 147 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2010 | 3 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 43 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 77 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2011 | 39 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 73 | 0.020 |
Why?
|
| Pongo | 1 | 2010 | 1 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2010 | 7 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 83 | 0.020 |
Why?
|
| Horses | 1 | 2010 | 14 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 125 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1990 | 4 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 1990 | 27 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2011 | 176 | 0.020 |
Why?
|
| Crown-Rump Length | 1 | 2009 | 1 | 0.020 |
Why?
|
| Amino Acid Transport System A | 1 | 2009 | 1 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2009 | 12 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2009 | 6 | 0.020 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Liver Glycogen | 1 | 2009 | 4 | 0.020 |
Why?
|
| Chorionic Villi | 1 | 2009 | 7 | 0.020 |
Why?
|
| E-Selectin | 1 | 2009 | 20 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Placentation | 1 | 2009 | 4 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2009 | 25 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 20 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 1989 | 65 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2009 | 30 | 0.020 |
Why?
|
| Leptin | 1 | 2009 | 69 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2009 | 48 | 0.020 |
Why?
|
| Amino Acids | 1 | 2009 | 49 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 70 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2009 | 37 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2009 | 11 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2009 | 82 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 244 | 0.020 |
Why?
|
| Apolipoproteins A | 1 | 1988 | 25 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2009 | 86 | 0.020 |
Why?
|
| Apolipoproteins C | 1 | 1988 | 4 | 0.020 |
Why?
|
| Anthropometry | 1 | 2008 | 86 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 213 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 110 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 503 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2008 | 19 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2008 | 90 | 0.020 |
Why?
|
| Intestines | 1 | 2008 | 61 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 3 | 0.020 |
Why?
|
| Aged | 2 | 2011 | 10398 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 1281 | 0.020 |
Why?
|
| Central Nervous System | 2 | 1999 | 46 | 0.020 |
Why?
|
| Middle Aged | 2 | 2011 | 11949 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2006 | 10 | 0.020 |
Why?
|
| Models, Biological | 1 | 2008 | 397 | 0.020 |
Why?
|
| Resistin | 1 | 2005 | 4 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 1447 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2004 | 9 | 0.020 |
Why?
|
| Child | 1 | 2011 | 2472 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2006 | 681 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 13 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 110 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 3571 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 2002 | 5 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2002 | 5 | 0.010 |
Why?
|
| Particle Size | 1 | 2002 | 45 | 0.010 |
Why?
|
| Multifactorial Inheritance | 1 | 2002 | 21 | 0.010 |
Why?
|
| Lithium | 1 | 2001 | 5 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1989 | 13 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1989 | 24 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1999 | 15 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1999 | 21 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 40 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 1999 | 449 | 0.010 |
Why?
|
| Genes, Retinoblastoma | 1 | 1994 | 2 | 0.010 |
Why?
|
| DNA Probes | 1 | 1994 | 19 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 1994 | 3 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1994 | 18 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1994 | 66 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1994 | 78 | 0.010 |
Why?
|
| Apoptosis | 1 | 1994 | 368 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1988 | 50 | 0.010 |
Why?
|
| Apolipoprotein A-I | 1 | 1988 | 69 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1989 | 470 | 0.010 |
Why?
|
| Apolipoprotein C-I | 1 | 1988 | 4 | 0.000 |
Why?
|
| Macaca fascicularis | 1 | 1988 | 401 | 0.000 |
Why?
|